Sumner, Whitney
Kim, Sangwoo S.
Vitzthum, Lucas
Moore, Kevin
Atwood, Todd
Murphy, James
Miyauchi, Sayuri
Califano, Joseph A.
Mell, Loren K.
Mundt, Arno J.
Sharabi, Andrew B. https://orcid.org/0000-0003-2075-1197
Funding for this research was provided by:
National Institute of Dental and Craniofacial Research (R01 DE028563)
Article History
Received: 15 March 2021
Accepted: 28 July 2021
First Online: 9 August 2021
Declarations
:
: This study was approved by the University of California Human Research Protections Program.
: Not applicable.
: The authors declare competing financial interests: LKM reports University research funding from Merck, consultant fees from Bayer HealthCare, and other fees from Merck and E.R. Squibb & Sons outside the submitted work. A.B.S. reports University research funding and honoraria from Pfizer and Varian Medical Systems, consultant fees from Astrazeneca, and other fees from Merck. A.B.S. is the scientific founder and has an equity interest in Toragen Inc. outside the submitted work.